15K views · 316 reactions | Pemphigus vulgaris is an autoimmune skin disease that causes blisters and erosions of the mucous membranes, skin, or both. Rituximab is recommended as first-line therapy, but its effectiveness in comparison with a first-line glucocorticoid-sparing agent has not been extensively investigated. New research findings are summarized in a short video. https://nej.md/3vpTpBH | The New England Journal of Medicine | Facebook